Antipodes Partners’s Salesforce CRM Stock Holding History
Bought
Maintained
Sold
Other funds holding CRM
Antipodes Partners's CRM Position: Q2 2026 in Review
Antipodes Partners increased its Salesforce (CRM) stake by 9.5% in Q2 2026, buying an estimated $7.71M and bringing the position to 502,872 shares worth $78.8M. The position accounts for 1.44% of the portfolio, ranked #31.
Antipodes Partners first reported a position in CRM in Q4 2024 and has held it in 7 quarters since. The position peaked at $91.4M in Q4 2025. 2,467 funds tracked by Wall St. Rank hold CRM as of Q2 2026.
- Antipodes Partners held 502,872 shares of Salesforce worth $78.8M as of Q2 2026.
- Antipodes Partners bought 43,826 Salesforce shares in Q2 2026, an estimated $7.71M.
- Salesforce made up 1.44% of Antipodes Partners's portfolio in Q2 2026, its #31 holding.
- Antipodes Partners first reported a position in Salesforce in Q4 2024 and has held it in 7 quarters since.
- Antipodes Partners's Salesforce position peaked at $91.4M in Q4 2025.
- 2,467 funds tracked by Wall St. Rank held Salesforce as of Q2 2026.
Based on Antipodes Partners's 13F filing for Q2 2026, filed 6 Aug 2026.